1 December 2022 false Taxfiler 2024.6 08297327business:PrivateLimitedCompanyLtd2022-12-012023-11-30 082973272022-11-30 082973272022-12-012023-11-30 08297327business:AuditExemptWithAccountantsReport2022-12-012023-11-30 08297327business:FilletedAccounts2022-12-012023-11-30 082973272023-11-30 08297327business:Director12022-12-012023-11-30 08297327business:Director22022-12-012023-11-30 08297327business:RegisteredOffice2022-12-012023-11-30 082973272022-11-30 08297327core:WithinOneYear2023-11-30 08297327core:WithinOneYear2022-11-30 08297327core:AfterOneYear2023-11-30 08297327core:AfterOneYear2022-11-30 08297327core:ShareCapitalcore:PreviouslyStatedAmount2023-11-30 08297327core:ShareCapitalcore:PreviouslyStatedAmount2022-11-30 08297327core:SharePremiumcore:PreviouslyStatedAmount2023-11-30 08297327core:SharePremiumcore:PreviouslyStatedAmount2022-11-30 08297327core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-11-30 08297327core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-11-30 08297327core:PreviouslyStatedAmount2023-11-30 08297327core:PreviouslyStatedAmount2022-11-30 08297327business:SmallEntities2022-12-012023-11-30 08297327countries:EnglandWales2022-12-012023-11-30 08297327core:ComputerEquipment2022-12-012023-11-30 08297327core:ComputerEquipment2022-11-30 08297327core:ComputerEquipment2023-11-30 08297327business:OrdinaryShareClass12022-12-012023-11-30 08297327business:OrdinaryShareClass12021-12-012022-11-30 08297327business:Director112022-12-012023-11-30 08297327business:Director112022-11-30 08297327business:Director112023-11-30 082973272021-12-012022-11-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 08297327 (England and Wales)
DRUGINFO LTD Unaudited accounts for the year ended 30 November 2023
DRUGINFO LTD Unaudited accounts Contents
Page
- 2 -
DRUGINFO LTD Company Information for the year ended 30 November 2023
Directors
Mr. Mohammed Ghalib Khan Mr. Tucker Mcgaw
Company Number
08297327 (England and Wales)
Registered Office
51 STAR STREET LONDON W2 1QQ ENGLAND
Accountants
CLEARCUT ACCOUNTING LIMITED SUITE 2 PARKWAY 5 PARKWAY BUSINESS CENT 300 PRINCESS ROAD MANCHESTER M14 7HR
- 3 -
DRUGINFO LTD Statement of financial position as at 30 November 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
2,098 
128 
Current assets
Debtors
10,537 
47,772 
Cash at bank and in hand
(52)
5,683 
10,485 
53,455 
Creditors: amounts falling due within one year
(12,307)
(9,820)
Net current (liabilities)/assets
(1,822)
43,635 
Total assets less current liabilities
276 
43,763 
Creditors: amounts falling due after more than one year
- 
559 
Net assets
276 
44,322 
Capital and reserves
Called up share capital
1,053 
1,000 
Share premium
14,940 
14,940 
Profit and loss account
(15,717)
28,382 
Shareholders' funds
276 
44,322 
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 3 March 2025 and were signed on its behalf by
Mr. Mohammed Ghalib Khan Director Company Registration No. 08297327
- 4 -
DRUGINFO LTD Notes to the Accounts for the year ended 30 November 2023
1
Statutory information
DRUGINFO LTD is a private company, limited by shares, registered in England and Wales, registration number 08297327. The registered office is 51 STAR STREET, LONDON, W2 1QQ, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
Straight Line over 3 years
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 December 2022
380 
Additions
2,697 
At 30 November 2023
3,077 
Depreciation
At 1 December 2022
252 
Charge for the year
727 
At 30 November 2023
979 
Net book value
At 30 November 2023
2,098 
At 30 November 2022
128 
- 5 -
DRUGINFO LTD Notes to the Accounts for the year ended 30 November 2023
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Trade debtors
- 
44,000 
Other debtors
10,537 
3,772 
10,537 
47,772 
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
VAT
5,967 
3,480 
Taxes and social security
6,340 
6,340 
12,307 
9,820 
7
Creditors: amounts falling due after more than one year
2023 
2022 
£ 
£ 
Bank loans
- 
(559)
8
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
1,053 Ordinary shares of £1 each
1,053 
1,000 
Shares issued during the period:
53 Ordinary shares of £1 each
53 
9
Loans to directors
Brought Forward 
Advance/ credit 
Repaid 
Carried Forward 
£ 
£ 
£ 
£ 
Director Loan Account
2,832 
17,191 
10,045 
9,978 
2,832 
17,191 
10,045 
9,978 
10
Average number of employees
During the year the average number of employees was 0 (2022: 0).
- 6 -